China (Mainland)
Gadopentetic acid 99% purity CAS NO.80529-93-7
- FOB Price: USD: 1.00-1.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,
- Available Specifications:
99%(1-10)Kilogram
- Product Details
Keywords
- Gadopentetic acid 80529-93-7
- Gadopentetic acid Gadopentetic acid Gadopentetic acid
- Gadopentetic acid Gadopentetic acid Gadopentetic acid
Quick Details
- ProName: Gadopentetic acid 99% purity
- CasNo: 80529-93-7
- Molecular Formula: C14H20GdN3O10
- Appearance: white powder
- Application: intermediate Gadopentetic acid
- DeliveryTime: 3days
- PackAge: 25kg/drum，10kg/drum
- Port: china（beijing，shanghai，qingdao）
- ProductionCapacity: 500 Kilogram/Month
- Purity: 99%
- Storage: 20-25℃
- Transportation: by air or by sea
- LimitNum: 1 Kilogram
- Moisture Content: 0.1
- Impurity: 0.2
- Grade: Pharma Grade,Other
- assay: 99%
- Standard: EP9, USP40
- High Purity: 99.9%
- Grade: Pharma Grade
Superiority
Gadopentetic acid
Gadopentetic acid Gadopentetic acid
Gadopentetic acid Gadopentetic acid Gadopentetic acid
Gadopentetic acid
Gadopentetic acid Gadopentetic acid
Gadopentetic acid
Gadopentetic acid Gadopentetic acid
Gadopentetic acid is one of the trade names for a gadolinium -basedMRI contrast agent, usually administered as a salt of a complex of gadolinium with DTPA (diethylenetriaminepentacetate ) with the chemical formula A2[Gd(DTPA)(H2O)]; when cation A is the protonated form of theamino sugar meglumine the salt goes under the name "Gadopentetate dimeglumine". It was described in 1981 and introduced as the first MRI contrast agent in 1987. It is used to assist imaging of blood vessels and of inflamed or diseased tissue where the blood vessels become 'leaky'. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood–brain barrier. It is usually injected intravenously. Gd-DTPA is classed as an acyclic, ionic gadolinium contrast medium. Its paramagnetic property reduces the T1relaxation time (and to some extent the T2 and T2* relaxation times) inNMR, which is the source of its clinical utility.
Details
(aq)2-.png) |
|
|---|---|
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| Pregnancy cat. | |
| Legal status | |
| Pharmacokinetic data | |
| Half-life | Distribution half life 12 minutes, elimination half 100 minutes |
| Identifiers | |
| CAS number |
86050-77-3  |
| ATC code | V08CA01 |
| PubChem | CID 55466 |
| DrugBank | DB00789 |
| ChemSpider |
50087 |
| UNII |
RH248G8V27 |
| KEGG |
D01707 |
| ChEBI |
CHEBI:31797 |
| ChEMBL |
CHEMBL1200431  |
| Chemical data | |
| Formula | C28H54GdN5O20 |